These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 16630950)
1. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. Levi M; Choi G; Picavet C; Hack CE J Allergy Clin Immunol; 2006 Apr; 117(4):904-8. PubMed ID: 16630950 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078 [TBL] [Abstract][Full Text] [Related]
3. Hereditary angioedema: increased number of attacks after frequent treatments with C1 inhibitor concentrate. Bork K; Hardt J Am J Med; 2009 Aug; 122(8):780-3. PubMed ID: 19635282 [TBL] [Abstract][Full Text] [Related]
4. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272 [TBL] [Abstract][Full Text] [Related]
5. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Bygum A; Andersen KE; Mikkelsen CS Eur J Dermatol; 2009; 19(2):147-51. PubMed ID: 19264579 [TBL] [Abstract][Full Text] [Related]
6. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis. Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056 [TBL] [Abstract][Full Text] [Related]
7. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. Gadek JE; Hosea SW; Gelfand JA; Santaella M; Wickerhauser M; Triantaphyllopoulos DC; Frank MM N Engl J Med; 1980 Mar; 302(10):542-6. PubMed ID: 7351888 [TBL] [Abstract][Full Text] [Related]
8. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients. Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855 [TBL] [Abstract][Full Text] [Related]
9. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. Waytes AT; Rosen FS; Frank MM N Engl J Med; 1996 Jun; 334(25):1630-4. PubMed ID: 8628358 [TBL] [Abstract][Full Text] [Related]
10. Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per week. Bork K; Hardt J Int Arch Allergy Immunol; 2011; 154(1):81-8. PubMed ID: 20664282 [TBL] [Abstract][Full Text] [Related]
12. Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate. Tallroth GA Int Arch Allergy Immunol; 2011; 154(4):356-9. PubMed ID: 20975289 [TBL] [Abstract][Full Text] [Related]
13. Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Bork K; Meng G; Staubach P; Hardt J Transfusion; 2005 Nov; 45(11):1774-84. PubMed ID: 16271103 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772 [TBL] [Abstract][Full Text] [Related]
15. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Bork K; Hardt J; Schicketanz KH; Ressel N Arch Intern Med; 2003 May; 163(10):1229-35. PubMed ID: 12767961 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human C1-inhibitor in the treatment of acute angioedema attacks. Choi G; Soeters MR; Farkas H; Varga L; Obtulowicz K; Bilo B; Porebski G; Hack CE; Verdonk R; Nuijens J; Levi M Transfusion; 2007 Jun; 47(6):1028-32. PubMed ID: 17524093 [TBL] [Abstract][Full Text] [Related]
17. [Profhylaxis and treatment of hereditary and acquired angioedema at HUB; use of the C1-esterase inhibitor]. Pastó Cardona L; Bordas Orpinell J; Mercadal Orfila G; Pérez de la Vara A; Jódar Massanés R Farm Hosp; 2003; 27(6):346-52. PubMed ID: 14974880 [TBL] [Abstract][Full Text] [Related]
18. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks. Craig TJ; Rojavin MA; Machnig T; Keinecke HO; Bernstein JA Ann Allergy Asthma Immunol; 2013 Sep; 111(3):211-5. PubMed ID: 23987198 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study. Martinez-Saguer I; Rusicke E; Aygören-Pürsün E; von Hentig N; Klingebiel T; Kreuz W Transfusion; 2010 Feb; 50(2):354-60. PubMed ID: 19788511 [TBL] [Abstract][Full Text] [Related]
20. [Recombinant human C1-inhibitor is effective in the treatment of acute attacks of hereditary angioedema--case report]. Porebski G; Bilo B; Obtułowicz K; Obtułowicz P; Nuijens J Przegl Lek; 2005; 62(5):317-20. PubMed ID: 16334540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]